Skip to main content
. 2015 Sep 17;43(22):10760–10781. doi: 10.1093/nar/gkv934

Figure 7.

Figure 7.

Silencing of CITED2 reduces both chromatin relaxation and H3Ac/p53 complex loading on the ERCC1 promoter. (A) Reduction of chromatin relaxation markers following CITED2 silencing. HEK293 cells receiving the indicated treatments were processed for immunoblotting. (B) Enhanced p53 binding to the ERCC1 promoter following treatment with TSA. (C) Quantification of enhanced p53 binding to the ERCC1 promoter by TSA shown in (B). (D) Suppression of H3K9Ac/p53 binding to ERCC1 promoter by shCITED2. (E) Suppression of H3K14Ac/p53 binding to ERCC1 promoter by shCITED2.